FDA Inspection 1118669 — Alembic Pharmaceuticals Limited

Alembic Pharmaceuticals Limited — FEI 3013826490

The FDA completed an inspection of Alembic Pharmaceuticals Limited on Jan 8, 2020 in Vadodara. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jan 8, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Vadodara (India)

Additional Details

Bioanalytical BA/BE

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.